Growth Metrics

LifeMD (LFMD) Net Income towards Common Stockholders (2016 - 2025)

LifeMD filings provide 14 years of Net Income towards Common Stockholders readings, the most recent being $19.2 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 356.46% to $19.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.1 million, a 150.15% increase, with the full-year FY2025 number at $11.2 million, up 142.8% from a year prior.
  • Net Income towards Common Stockholders hit $19.2 million in Q4 2025 for LifeMD, up from -$4.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $19.2 million in Q4 2025 to a low of -$19.0 million in Q4 2021.
  • Median Net Income towards Common Stockholders over the past 5 years was -$7.5 million (2023), compared with a mean of -$7.4 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 398.08% in 2021 and later soared 356.46% in 2025.
  • LifeMD's Net Income towards Common Stockholders stood at -$19.0 million in 2021, then skyrocketed by 33.03% to -$12.7 million in 2022, then soared by 64.53% to -$4.5 million in 2023, then plummeted by 65.94% to -$7.5 million in 2024, then surged by 356.46% to $19.2 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were $19.2 million (Q4 2025), -$4.6 million (Q3 2025), and $455210.0 (Q2 2025) per Business Quant data.